BioCryst Pharma (BCRX) PT Lowered to $21 at JPMorgan

February 25, 2022 9:07 AM EST Send to a Friend

JPMorgan analyst Jessica Fye lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

BioCryst Pharma (BCRX) PT Lowered to $21 at JPMorgan

Member Login

Free News Feed